A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans. - Wikidata - awgldk - TriplyDB

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

http://www.wikidata.org/entity/Q36894582

about

The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders Meta-Analyses of Genome-Wide Association Data Hold New Promise for Addiction Genetics.Inhalation of Alcohol Vapor: Measurement and Implications.Intravenous Nicotine Self-Administration in Smokers: Dose-Response Function and Sex Differences.GLP-1 acts on habenular avoidance circuits to control nicotine intake.Atomoxetine in abstinent cocaine users: Sex differences.Phenome-Wide Association Study for Alcohol and Nicotine Risk Alleles in 26394 Women.How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects.Cognitive Effects of Nicotine: Recent Progress.Biochemical Diagnosis in Substance and Non-substance Addiction.Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.

P2860

Q28072077-83CC5E54-2CD1-4AD3-AA8C-6643A6E22E1E Q28080064-C169EAC2-18B6-4676-891D-A320B34A1F05 Q31126353-4AE94B2E-7956-4495-8DEF-85C4A2A7D87E Q34548568-C976DF40-EBE7-4D5A-AF45-07E26DAD7F2F Q37006307-C078211D-7D11-4B10-A42E-9518771BDED6 Q38432197-B64C623F-B158-42A7-951A-9419FDE287F1 Q38598616-85333578-0AFC-4C5C-86DE-6EC908EA91CC Q40751145-7F21139D-4D51-4512-878F-FD21EF01A675 Q42615631-DC2B6685-C09A-49C3-A661-27BDE554C5F7 Q47823644-398ED13E-130F-4F6D-A0D3-635FE0B6B934 Q48609200-869E7F06-3F13-4840-8697-B26F7F6427E7 Q52314530-709E3EEB-FD99-4B5C-B62E-3A52E965D0BA Q55039412-4814608F-E1E8-4A91-A250-55616AA3EF1B

P2860

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

http://www.wikidata.org/entity/Q36894582

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

@en

type

label

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

@en

prefLabel

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

@en

P1433

Q36894582-474E5E7A-F64A-4ACD-BA72-D1078D4FF3F7

P1476

Q36894582-F5C53346-B700-4AE6-8567-25BBF4FB74D5

P2093

Q36894582-00DBB972-E1FC-43F7-B74B-4A53620923E1

Q36894582-425D6EA8-C3A0-4AAE-914D-20FB9EB9329C

Q36894582-E8B675A7-AC38-4C15-9AE0-642DBDF49D45

Q36894582-E8F72036-F3BE-4572-893D-743ABDA25FB0

Q36894582-F584682D-7A3D-427B-A2FD-9141C15D9DF9

P2860

Q36894582-009C5037-9BCE-4B5E-A7F6-C312FA72A625

Q36894582-06AAABE6-CDD8-4C89-A5A5-DCAFAD4E2D48

Q36894582-078E6406-8396-4C89-82A3-4AF5B129EAF3

Q36894582-0DAC84D4-D180-4602-82AF-0346C62D2A37

Q36894582-0E3F9739-FE2A-4E3B-9182-0F08F4F9FF83

Q36894582-0E9F7465-2265-43CE-B6B9-79815664993E

Q36894582-11C7316C-FE29-4205-A265-6AF6729C3AFB

Q36894582-1359AA5C-E2A8-4D88-8B43-37C13988D6E7

Q36894582-172C2046-9E5D-423C-8A5A-F2C80AE1849B

Q36894582-1DEF7126-981A-487D-A7F8-D3BC1AA4E566

P2888

Q36894582-4436C559-6CA2-4749-8EB1-E88B88AE4B14

P304

Q36894582-2D55A5AF-6169-45C3-8075-D66190E9EE5A

P31

Q36894582-43BF71D0-6425-47D4-B24A-14BA13016B2C

P356

Q36894582-9E6668A4-C758-43E8-A0A1-5B281F2A9D40

P407

Q36894582-4D44BC37-DD8D-45F1-9711-E005FBEBC988

P433

Q36894582-06B91964-F8FD-45DB-99EC-11439276130A

P478

Q36894582-6E6BEF40-603A-4499-A34B-4A33765C73B0

P50

Q36894582-B70B4070-BA6E-4004-BCA5-767354D1D0E8

P577

Q36894582-7B8B0395-36C7-489B-903E-FEF5C1D12288

P6179

Q36894582-FEF6F558-0C9F-4DE3-911A-635343C1C606

P698

Q36894582-7DD99B6A-5F5F-4323-9EF8-FB26E0D43B1E

P932

Q36894582-A4ABF49E-06C6-4437-829C-A81ABF314574

P356

P1433

Neuropsychopharmacology

P1476

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

@en

P2093

Aryeh I Herman

http://www.w3.org/2001/XMLSchema#string

Elise E DeVito

http://www.w3.org/2001/XMLSchema#string

Gerald W Valentine

http://www.w3.org/2001/XMLSchema#string

Kevin P Jensen

http://www.w3.org/2001/XMLSchema#string

Mehmet Sofuoglu

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis and imputation refines the association of 15q25 with smoking quantity

Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking

Genome-wide meta-analyses identify multiple loci associated with smoking behavior.

Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes

Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

Novel genes identified in a high-density genome wide association study for nicotine dependence

Development and validation of brief measures of positive and negative affect: the PANAS scales

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

P2888

P304

2813-2821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2015.131

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002757216

http://www.w3.org/2001/XMLSchema#string

P698

25948103

http://www.w3.org/2001/XMLSchema#string

P932

4864657

http://www.w3.org/2001/XMLSchema#string